Showing results (11-20 of 136) with videos related to
Sort By:
Pageof 14
Annals of Surgical Oncology|October 16, 2009
Isolated limb infusion for malignant melanoma: predictors of response and outcomeAndrew P Barbour, Janine Thomas, Jennifer Suffolk, et al.Annals of Surgical Oncology|January 8, 2011
Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomyJodi Hirst, Bernard Mark Smithers, David C Gotley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, AustraliaAdèle C Green, Peter Baade, Michael Coory, et al.ANZ Journal of Surgery|March 27, 2023
Trends and patterns of care of sentinel node biopsy in cutaneous melanoma: a population-based study in QueenslandJessica Wong, Julie Moore, H Peter Soyer, et al.ANZ Journal of Surgery|March 28, 2008
Desmoplastic melanoma: the role of radiotherapy in improving local controlMatthew C Foote, Bryan Burmeister, Elizabeth Burmeister, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 19, 2019
Pancreaticoduodenectomy in a low-resection volume region: a population-level study examining the impact of hospital-volume on surgical quality and longer-term survivalAaditya Narendra, Peter D Baade, Joanne F Aitken, et al.ANZ Journal of Surgery|December 17, 2019
Impact of hospital resection volume and service capability on post-operative mortality following gastrectomyAaditya Narendra, Peter D Baade, Joanne F Aitken, et al.ANZ Journal of Surgery|August 18, 2021
Procedure-specific outcomes following gastrectomy for cancer compared by hospital volume and service capabilityKevin Tian, Peter D Baade, Joanne F Aitken, et al.Journal of Surgical Oncology|February 24, 2017
Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanomaMatthew Foote, Tavis Read, Janine Thomas, et al.The Lancet. Oncology|March 3, 2007
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisVal Gebski, Bryan Burmeister, B Mark Smithers, et al.Pageof 14